In the last trading session, 34.39 million Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) shares changed hands as the company’s beta touched 1.80. With the company’s per share price at $0.64 changed hands at $0.04 or 6.23% during last session, the market valuation stood at $3.22M. QNRX’s last price was a discount, traded about -865.62% off its 52-week high of $6.18. The share price had its 52-week low at $0.48, which suggests the last value was 25.0% up since then. When we look at Quoin Pharmaceuticals Ltd ADR’s average trading volume, we note the 10-day average is 92650.0 shares, with the 3-month average coming to 2.63 million.
Analysts gave the Quoin Pharmaceuticals Ltd ADR (QNRX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended QNRX as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) trade information
Instantly QNRX was in green as seen at the end of in last trading. With action 8.96%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -87.01%, with the 5-day performance at 8.96% in the green. However, in the 30-day time frame, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) is -14.68% down. Looking at the short shares, we see there were 19172.0 shares sold at short interest cover period of 0.2 days.
Quoin Pharmaceuticals Ltd ADR (QNRX) estimates and forecasts
Data shows that the Quoin Pharmaceuticals Ltd ADR share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -15.01% over the past 6 months, a 78.73% in annual growth rate that is considerably higher than the industry average of 16.50%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -194.79%. The 2024 estimates are for Quoin Pharmaceuticals Ltd ADR earnings to increase by 78.42%.
QNRX Dividends
Quoin Pharmaceuticals Ltd ADR is expected to release its next quarterly earnings report in January.
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 2.45% of Quoin Pharmaceuticals Ltd ADR shares while 5.89% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 6.03%.
